Across 1 buy signal with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Discover the full record of transactions filed by Sullivan Lynne Marie, Chief Financial Officer. Insider active across 2 companies, notably Unity Biotechnology, Inc.. Cumulatively, 10 filings have been logged. Split: 1 buy · 5 sells. Total volume traded: €64k. History available since 24 June 2021. The latest transaction was disclosed on 2 April 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to Sullivan Lynne Marie
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
30,833 shares0Common Stock, $0.0001 par valueSEC:0000899243-21-026230:0
10 of 10 declarations
About Sullivan Lynne Marie
Sullivan Lynne Marie is Director Financier. She is linked to Unity Biotechnology, Inc. as CFO & Head of Corp. Dev., and to BiomX Inc. as Director. The total number of filings is 10, and, across the sampled recent filings from 2021-06-28 to 2025-04-03, the amounts shown are EUR 42208 for buys and EUR 21759 for sells, with a modal transaction nature of Cession.